Every one of those 2 sits in a single category, regulation. CalMatters is most often covered alongside California Institute for Immunology and Immunotherapy, which appears in 1 of these 2 stories. The 34-day window averages about 0.4 stories each week.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about CalMatters
Every one of those 2 sits in a single category, regulation. CalMatters is most often covered alongside California Institute for Immunology and Immunotherapy, which appears in 1 of these 2 stories. The 34-day window averages about 0.4 stories each week. Each story carries 2 original sources on average, compared with 2.5 for the broader beat in this window. At 6.5, the average consequence score sits above the same-window beat average of 5.9. We currently track 2 Legal stories that mention CalMatters, published between July 21, 2026 and August 23, 2026.
Stories tracked
2
Per week
0.4
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 469 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering CalMatters. Shared-story counts are live from our verified record — not editorial picks.
Editorial boards flag that half of Proposition 38's $8.4 billion in bonds would flow to one nonprofit institute whose billionaire co-founder is the measure's chief backer. Legal professionals may see conflict-of-interest, public accountability, and ballot-box budgeting issues.
The Trump administration's admission that it used keyword filters to cancel nearly $2B in research grants at UC strengthens a lawsuit alleging First Amendment violations. Plaintiffs now seek summary judgment, bypassing a full trial, with a hearing set for October 20.
CalMatters is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.